Ved Prakash Dwivedi
11PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Oct 13, 2025
Carglumic acid and mesalazine as potential anti-mycobacterial agents: a spectroscopic study for repurposing drugs against Mycobacterium tuberculosis targeting its essential enzyme ThyX.Sana Tanweer, Meetu Agarwal, Kunal Malik
|May 29, 2024
Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence.Isha Pahuja, Antara Ghoshal, Ahmed Abdallah Okieh
|Oct 20, 2023
Adjunct Therapy With All-trans-Retinoic Acid Improves Therapeutic Efficacy Through Immunomodulation While Treating Tuberculosis With Antibiotics in Mice.Baldeep Singh, Isha Pahuja, Priyanka Yadav
|Jun 08, 2023
Cotreatment With Clofazimine and Rapamycin Eliminates Drug-Resistant Tuberculosis by Inducing Polyfunctional Central Memory T-Cell Responses.Dhiraj Kumar Singh, Ashima Bhaskar, Isha Pahuja
|Jun 05, 2023
Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis.Isha Pahuja, Akanksha Verma, Antara Ghoshal
|May 12, 2023
Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases.Annu Devi, Isha Pahuja, Shashi Prakash Singh
Pageof 2
